Video
23 Jun 2021
LSNE Corporate Overview - Delivering On Our Promises
Content provided by our supplier
LSNE Contract Manufacturing
-
US
-
2015On CPHI since
-
250 - 499Employees
Company types
Other Content from LSNE Contract Manufacturing (1)
-
News LSNE Receives Approval from AEMPS to Manufacture Biotechnology-based Therapeutic Products
LSNE expands capabilities for aseptic fill finish of high-value biologics in Europe. This important approval builds upon LSNE’s well-established capabilities in providing aseptic fill finish of biologic products for clients at its US facilities. These products include monoclonal antibodies, fusion proteins, replacement enzymes, plasmids, capsids, and oligonucleotides.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance